Medtronic to Participate in the Piper Jaffray PCR Post-Op Summit

Medtronic, Inc. (NYSE: MDT), the world’s leading medical technology company, today announced it will participate in the Piper Jaffray PCR Post-Op Summit on Friday, May 22, 2009, in London.

Scott Ward, president of the CardioVascular business and senior vice president at Medtronic, will speak to the attendees of the conference at 8 a.m. British Summer Time (2 a.m. Central Daylight Time). Ward will provide remarks highlighting Medtronic’s activities and product news from the EuroPCR conference. A live audio webcast of the presentation will be available to all interested parties at Medtronic’s Investor Relations website at http://www.medtronic.com/.

About Medtronic

Medtronic, Inc. (www.medtronic.com), headquartered in Minneapolis, is the global leader in medical technology – alleviating pain, restoring health, and extending life for millions of people around the world.